Interactive Response Technology - IXRS®3

IRT Solutions Almac

Used in more than 2,000 clinical trials and at over 130,000 sites around the world

Over the past several years, clinical trials have become increasingly intricate. Study sponsors now aim to satisfy multiple objectives within a single, more complex protocol. As the level of complexity grows, it’s imperative that the technology employed to capture this critical data keeps up. We have earned a reputation for providing a level of flexibility that is unmatched in the industry.

Available in multiple modalities, our market-leading solution for patient randomisation and trial supply management is the most configurable and customisable interactive response technology available. From Phase I through to IV, simple designs to complex adaptive trials, IXRS®3 easily accommodate any permutation of study objectives.

IXRS®3 – Intuitive, sophisticated and reliable Interactive Response Technology

IXRS®3 offers an intuitive and logical way to manage the key components of clinical trials including: screening, randomisation, dosing, drug supply/inventory management, patient tracking, clinical outcomes assessments and more – providing access to pertinent data points and actionable insight across studies and programs.

Our sophisticated supply management capabilities, allow our Project Managers to collaborate with sponsor teams to find the optimal balance of inventory to minimise supply costs and  maximise successful patient resupply throughout your study.

Almac IXRS

Related Resources